Literature DB >> 8985364

The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines.

Z He1, Y S He, Y Kim, L Chu, C Ohmstede, K K Biron, D M Coen.   

Abstract

The product of the human cytomegalovirus (CMV) UL97 gene, which controls ganciclovir phosphorylation in virus-infected cells, is homologous to known protein kinases but diverges from them at a number of positions that are functionally important. To investigate UL97, we raised an antibody against it and overexpressed it in baculovirus-infected insect cells. Recombinant baculovirus expressing full-length UL97 directed the phosphorylation of ganciclovir in insect cells, which was abolished by a four-codon deletion that confers ganciclovir resistance to CMV. When incubated with [gamma-32P]ATP, full-length UL97 was phosphorylated on serine and threonine residues. Phosphorylation was severely impaired by a point mutation that alters lysine-355 in a motif that aligns with subdomain II of protein kinases. However, phosphorylation was impaired much less severely by the four-codon deletion. A UL97 fusion protein expressed from recombinant baculovirus was purified to near homogeneity. It too was phosphorylated upon incubation with [gamma-32P]ATP in vitro. This phosphorylation, which was abolished by the lysine 355 mutation, was optimal at high NaCl and high pH. The activity required either Mn2+ or Mg2+, with a preference for Mn2+, and utilized either ATP or GTP as a phosphate donor, with Kms of 2 and 4 microM, respectively. The phosphorylation rate was first order with protein concentration, consistent with autophosphorylation. These data strongly argue that UL97 is a serine/threonine protein kinase that autophosphorylates and suggest that the four-codon deletion affects its substrate specificity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985364      PMCID: PMC191065     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.

Authors:  F Baldanti; M R Underwood; S C Stanat; K K Biron; S Chou; A Sarasini; E Silini; G Gerna
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

2.  Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir.

Authors:  M N Hanson; L C Preheim; S Chou; C L Talarico; K K Biron; A Erice
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

3.  Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates.

Authors:  S Chou; S Guentzel; K R Michels; R C Miner; W L Drew
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

4.  Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance.

Authors:  S Chou; A Erice; M C Jordan; G M Vercellotti; K R Michels; C L Talarico; S C Stanat; K K Biron
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

5.  The varicella-zoster virus (VZV) open reading frame 47 (ORF47) protein kinase is dispensable for viral replication and is not required for phosphorylation of ORF63 protein, the VZV homolog of herpes simplex virus ICP22.

Authors:  T C Heineman; J I Cohen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Human cytomegalovirus UL97 kinase confers ganciclovir susceptibility to recombinant vaccinia virus.

Authors:  C Metzger; D Michel; K Schneider; A Lüske; H J Schlicht; T Mertens
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease.

Authors:  D G Wolf; D J Lee; S A Spector
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

8.  Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma.

Authors:  D G Wolf; I L Smith; D J Lee; W R Freeman; M Flores-Aguilar; S A Spector
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

9.  A three-nucleotide deletion in the UL97 open reading frame is responsible for the ganciclovir resistance of a human cytomegalovirus clinical isolate.

Authors:  F Baldanti; E Silini; A Sarasini; C L Talarico; S C Stanat; K K Biron; M Furione; F Bono; G Palù; G Gerna
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir.

Authors:  E Littler; A D Stuart; M S Chee
Journal:  Nature       Date:  1992-07-09       Impact factor: 49.962

View more
  72 in total

1.  Emergence of multiple human cytomegalovirus ganciclovir-resistant mutants with deletions and substitutions within the UL97 gene in a patient with severe combined immunodeficiency.

Authors:  D G Wolf; I Yaniv; S Ashkenazi; A Honigman
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation.

Authors:  D G Wolf; C T Courcelle; M N Prichard; E S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  Autophosphorylation of p110delta phosphoinositide 3-kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo.

Authors:  B Vanhaesebroeck; K Higashi; C Raven; M Welham; S Anderson; P Brennan; S G Ward; M D Waterfield
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

Review 4.  Herpesvirus homologues of cellular genes.

Authors:  M Raftery; A Müller; G Schönrich
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

5.  Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.

Authors:  Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus.

Authors:  Paula M Krosky; Katherine Z Borysko; M Reza Nassiri; Rodrigo V Devivar; Roger G Ptak; Michelle G Davis; Karen K Biron; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

7.  The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase.

Authors:  Paula M Krosky; Moon-Chang Baek; Wan Jin Jahng; Imma Barrera; Robert J Harvey; Karen K Biron; Donald M Coen; Phiroze B Sethna
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 8.  Viral serine/threonine protein kinases.

Authors:  Thary Jacob; Céline Van den Broeke; Herman W Favoreel
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

9.  Human cytomegalovirus UL97 Kinase is required for the normal intranuclear distribution of pp65 and virion morphogenesis.

Authors:  Mark N Prichard; William J Britt; Shannon L Daily; Caroll B Hartline; Earl R Kern
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

10.  Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.

Authors:  Karen K Biron; Robert J Harvey; Stanley C Chamberlain; Steven S Good; Albert A Smith; Michelle G Davis; Christine L Talarico; Wayne H Miller; Robert Ferris; Ronna E Dornsife; Sylvia C Stanat; John C Drach; Leroy B Townsend; George W Koszalka
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.